BG100246A - N-substituted azaheterocylic carboxylic acids and their esters - Google Patents

N-substituted azaheterocylic carboxylic acids and their esters

Info

Publication number
BG100246A
BG100246A BG100246A BG10024695A BG100246A BG 100246 A BG100246 A BG 100246A BG 100246 A BG100246 A BG 100246A BG 10024695 A BG10024695 A BG 10024695A BG 100246 A BG100246 A BG 100246A
Authority
BG
Bulgaria
Prior art keywords
azaheterocylic
esters
substituted
carboxylic acids
compounds
Prior art date
Application number
BG100246A
Other languages
Bulgarian (bg)
English (en)
Inventor
Jesper Lau
Hans Petersen
Knud Andersen
Per Sorensen
Friedrich Lundt
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of BG100246A publication Critical patent/BG100246A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG100246A 1993-06-23 1995-12-21 N-substituted azaheterocylic carboxylic acids and their esters BG100246A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93746A DK74693D0 (da) 1993-06-23 1993-06-23 Novel heterocyclic chemistry
PCT/DK1994/000253 WO1995000486A1 (en) 1993-06-23 1994-06-22 N-substituted azaheterocyclic carboxylic acids and esters thereof

Publications (1)

Publication Number Publication Date
BG100246A true BG100246A (en) 1996-07-31

Family

ID=8097063

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100246A BG100246A (en) 1993-06-23 1995-12-21 N-substituted azaheterocylic carboxylic acids and their esters

Country Status (16)

Country Link
US (1) US5604242A (ja)
EP (1) EP0705248A1 (ja)
JP (1) JPH08511783A (ja)
CN (1) CN1128989A (ja)
AU (1) AU7067794A (ja)
BG (1) BG100246A (ja)
CA (1) CA2165946A1 (ja)
CZ (1) CZ335495A3 (ja)
DK (1) DK74693D0 (ja)
FI (1) FI956177A7 (ja)
HU (1) HUT75303A (ja)
IL (1) IL110078A0 (ja)
NO (1) NO955263L (ja)
SK (1) SK162795A3 (ja)
WO (1) WO1995000486A1 (ja)
ZA (1) ZA944470B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4549452B2 (ja) * 1997-12-12 2010-09-22 富山化学工業株式会社 アルキルエーテル誘導体またはその塩並びにそれらを含有するカルシウム拮抗剤
AU1506499A (en) * 1997-12-12 1999-07-05 Toyama Chemical Co. Ltd. Alkyl ether derivatives or salts thereof and calcium antagonists containing the same
BRPI0213393B8 (pt) 2001-10-19 2021-05-25 Fujifilm Toyama Chemical Co Ltd derivados de éter alquílico, ou um de seus sais, processo para produzir um derivado de éter alquílico, derivado de alquil-amida, ou um de seus sais, e, composição farmacêutica
CN1382441A (zh) * 2002-05-21 2002-12-04 中国科学院上海生命科学研究院 γ－氨基丁酸转运蛋白抑制剂在制备镇痛药物中的应用
ES2391273T3 (es) * 2003-04-17 2012-11-23 Toyama Chemical Co., Ltd. Agente preventivo/curativo para enfermedades del nervio retiniano que contiene derivados de éter alquílico o sus sales
MXPA06014026A (es) * 2004-07-02 2007-02-08 Warner Lambert Co Composiciones y metodos para tratar infecciones patogenas.
DE102006053500A1 (de) 2006-11-14 2008-05-15 Evonik Goldschmidt Gmbh Antimikrobielle Zusammensetzungen
EP2481465A4 (en) * 2009-09-24 2014-09-24 Toshiba Kk CARBON DIOXIDE ABSORBING SOLUTION
CA3050255A1 (en) 2017-01-20 2018-07-26 The Regents Of The University Of California Inhibitors of the n-terminal domain of the androgen receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910312A (en) * 1985-11-08 1990-03-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
DK588189D0 (da) * 1989-11-22 1989-11-22 Novo Nordisk As Nye heterocykliske carboxylsyrer
DK93791D0 (da) * 1991-05-17 1991-05-17 Novo Nordisk As Nye heterocykliske carboxylsyrer

Also Published As

Publication number Publication date
NO955263D0 (no) 1995-12-22
DK74693D0 (da) 1993-06-23
WO1995000486A1 (en) 1995-01-05
FI956177A0 (fi) 1995-12-21
CN1128989A (zh) 1996-08-14
ZA944470B (en) 1995-12-22
HU9503755D0 (en) 1996-02-28
JPH08511783A (ja) 1996-12-10
AU7067794A (en) 1995-01-17
NO955263L (no) 1996-02-22
EP0705248A1 (en) 1996-04-10
IL110078A0 (en) 1994-10-07
SK162795A3 (en) 1996-09-04
US5604242A (en) 1997-02-18
FI956177L (fi) 1996-02-21
HUT75303A (en) 1997-05-28
CZ335495A3 (en) 1996-07-17
FI956177A7 (fi) 1996-02-21
CA2165946A1 (en) 1995-01-05

Similar Documents

Publication Publication Date Title
UA29450C2 (uk) Похідні гідроксамової кислоти, спосіб їх одержання, спосіб впливу на хвороби та фармацевтична або ветеринарна композиція, що їх містить
NO934768L (no) Sammensetning av L-DOPA-estere
UA41906C2 (uk) Спосіб лікування неврологічних порушень, викликаних травмами
CA2219115A1 (en) N-benzyl-3-indoleacetic acids as cyclooxygenase-2-inhibitors and antiinflammatory drugs
AU3249295A (en) Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
HUT71344A (en) Pharmaceutical compositions for inhibiting thrombin containing 2-phenyl-3-aroyl-benzothiophene derivatives and process for their preparation
BG100246A (en) N-substituted azaheterocylic carboxylic acids and their esters
IL97796A0 (en) Pharmaceutical compositions containing n-alkylated 1,4-dihydropyridine-dicarboxylic acid esters,certain such compounds and their preparation
PT736029E (pt) Sulfamatos de pseudofructopiranose anticonvulsivos
CA2211320A1 (en) 5-methanesulfonamido-3h-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2
NO864443D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive n-substituerte 3-piperidin- eller 3-pyridin-karboksylsyrederivater.
FI103116B1 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten, N-substituoitujen atsaheterosyklisten karboksyylihappojohdannaisten valmistamiseksi
MX9800704A (es) Esteres y amidas como inhibidores de fosfolipasa a2.
IL88740A (en) Pharmaceutical compositions containing n-n-butyl deoxynojirimycin for treating aids
CA2301590A1 (en) 2-aminopyridines as inhibitors of cyclooxygenase-2
AU2287197A (en) Heterocyclic compounds and their preparation and use
UA66751C2 (en) Benzamides as medicament for treatment of neurodegenerative state, a method for the preparation thereof (variants), pharnaceutical composition for treatment of neurodegenerative states and a method for treatment
HU9302778D0 (en) Process for preparing acyl-sulfonamido-and sulfonamido-pyridine-2-carboxylic acid esters and pharmaceutical compositions containing them
KR910020023A (ko) 헤테로사이클릭-nmda길항제
ZA961795B (en) Pharmaceuticals
WO1997019669A3 (en) Heterocyclic compounds and their use
BG100244A (en) N-substituted azaheterocyclic carboxylic acids and their esters
HU9303016D0 (en) Process for producing pharmaceutical compositions of antiflogistic and analgesic activity from medical plants